Wall Street Journal report on an undercover operation by US congress on institutional review boards

The full piece, published on March 26th, which describes the operation as being a "congressional sting operation" is here, excerpt:

"The sting, detailed at a House Energy and Commerce Committee hearing Thursday, involved the creation of a fictitious company and a fake medical device, a surgical adhesive gel. The sham firm then applied to three for-profit oversight groups — called institutional review boards, or IRBs — for approval to begin a clinical trial using their adhesive on human subjects."

One company did approve the protocol. The company's CEO described the sting as "illegal entrapment".

Comments

  • Posted by Ginny Barbour, 17/4/2009 10.28pm

An update on this story is featured in the New York Times